These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 7731134)
1. Is beta 2-microglobulin a mediator of bone disease? Sprague SM; Popovtzer MM Kidney Int; 1995 Jan; 47(1):1-6. PubMed ID: 7731134 [No Abstract] [Full Text] [Related]
2. Skeletal amyloidosis due to beta microglobulinemia in a patient on hemodialysis. A case report. Hadjipavlou A; Lander P; Begin L; Bercovitch D; Davidman M; Jakab E J Bone Joint Surg Am; 1988 Jan; 70(1):119-21. PubMed ID: 3275669 [No Abstract] [Full Text] [Related]
16. [Morphology and diagnosis of hemodialysis--related amyloidosis]. Ohashi K; Kawai R; Hara M Nihon Rinsho; 1992 Jan; 50 Suppl():801-6. PubMed ID: 1578770 [No Abstract] [Full Text] [Related]
17. New aspects in the pathogenesis of dialysis-related amyloidosis: role of beta 2-microglobulin modified with advanced glycation end products in bone and joint destruction. Miyata T; Maeda K Nephrol Dial Transplant; 1996; 11 Suppl 2():140-3. PubMed ID: 8804015 [No Abstract] [Full Text] [Related]
18. Pathogenesis and management of dialysis-related amyloid bone disease. Nangaku M; Miyata T; Kurokawa K Am J Med Sci; 1999 Jun; 317(6):410-5. PubMed ID: 10372842 [TBL] [Abstract][Full Text] [Related]
19. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure. Miyata T Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608 [TBL] [Abstract][Full Text] [Related]
20. Osteoarticular amyloidosis associated with haemodialysis: an immunoultrastructural study. Depierreux M; Goldman M; Fayt I; Richard C; Quintin J; Dhaene M; Van Herweghem JL J Clin Pathol; 1988 Feb; 41(2):158-62. PubMed ID: 3280607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]